Business

ZLD Completes Enrolment for Diabetic Nerve Pain Drug Trial

ZLD Completes Enrolment for Diabetic Nerve Pain Drug Trial

Zelira Therapeutics Ltd.November 20, 20223
ZLD Completes Enrolment for Diabetic Nerve Pain Drug Trial

About this update from Zelira Therapeutics Ltd.

Zelira Therapeutics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Zelira Therapeutics Ltd.

More from Zelira Therapeutics Ltd.

All Zelira Therapeutics Ltd. news →